Carefusion, Baxter, Fresenius Lead Growing European Infusion Therapy Market with Home and Alternate Care Sales

News provided by

Aug 29, 2011, 07:45 ET

Needleless Connector Device Classification Confusion in Europe Stifles Sales Growth Potential

VANCOUVER, Aug. 29, 2011 /PRNewswire/ - According to a new report by iData Research (www.idataresearch.net), the leading global authority in medical device market research, the European infusion therapy device market, which includes needleless connectors, infusion pumps and intravenous (IV) sets, was valued at an estimated €443 million in 2010. This market is expected to reach almost €533 million by 2017 driven by the rising use of disposable ambulatory infusion pumps, particularly in the home/alternate care settings. In addition, the introduction of low-cost Chinese and South Korean distributors in Italy and Spain has boosted sales volumes in those countries, despite the economic turmoil.

"In 2010, disposable ambulatory and syringe infusion pumps were the fastest-growing segments in the European infusion pump market," says Dr. Kamran Zamanian, CEO of iData. "The rise of home/alternate care clinical settings is driving the disposable market due to substantial pressure on the European health care system to cut costs and discharge patients sooner. By 2017, over 68% of disposable ambulatory infusion pumps sold in Europe will be in the home/alternate care setting."

The report states that Baxter, B. Braun and Fresenius were leading the disposable infusion pump market in 2010, particularly in Germany, France and the U.K, which had the largest markets. In the same countries Becton Dickinson, ICU Medical and Vygon led the needleless connector market, which is expected to see modest growth.

"There is no clinical definition in Europe of what is considered positive, negative or neutral displacement within the needleless connector market," says Dr. Zamanian. "This is causing confusion among consumers, who are staying with familiar technology, thus limiting market growth. However, further legislation and protocols surrounding the reduction of needle-stick injuries is expected to help counter-act these effects."

For more information, register free on iData's website at:
http://www.idataresearch.net/idata/registration.php

iData's 3-report series on "The Markets for Infusion Therapy Devices 2011" includes the U.S., 15 countries in Europe and Asia-Pacific. This report provides the latest data and market-analyses for over 10 segments.

About iData Research

iData Research (www.idataresearch.net/idata/discoveridata.php) is an international market research and consulting group focused on providing market intelligence for medical device and pharmaceutical companies. iData covers research in: vascular access, cardiology, cardiac surgery and more.

SOURCE iData Research Inc.